This resolution provides for the consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the concurrent resolution (H. Con. Res. 113) establishing the congressional budget for the United States Government for fiscal year 2027 and setting forth the appropriate budgetary levels for fiscal years 2028 through 2036; providing for consideration of the bill (H.R. 7008) to amend chapter 131 of title 5 to require certain restrictions on stocks for Members of Congress and their spouses and dependents, and for other purposes; providing for consideration of the bill (H.R. 6955) to make improvements to the Federal banking laws, and for other purposes; providing for consideration of the bill (H.R. 9770) making continuing appropriations for fiscal year 2027, and for other purposes; and for other purposes.
The Secure Drug Supply Chain Act of 2026 aims to protect the U.S. pharmaceutical supply by preventing the importation of counterfeit or unsafe drugs from countries like China and others designated as adversarial. It requires drug manufacturers to report quarterly details about the origins of their active ingredients and key starting materials, specifically highlighting those sourced from China or other foreign countries of concern. The bill also strengthens enforcement by allowing the government to ban imports from facilities using forced labor or violating sanctions, and it mandates the destruction of refused drugs that pose significant public health risks. Additionally, the law establishes new reporting requirements to track supply chain vulnerabilities and directs the Health and Human Services Secretary to issue regulations and guidance to implement these measures.
The Justice for Incarcerated Moms Act aims to improve maternal health outcomes for pregnant and postpartum individuals in the criminal justice system by restricting financial incentives for states that use restraints on pregnant inmates. Under the bill, states receiving federal justice grants would face a 25 percent funding penalty if they fail to implement laws limiting the use of shackles on pregnant individuals, with those withheld funds redirected to compliant states. The legislation also directs the Bureau of Prisons and the Department of Justice to create and fund programs in at least six federal facilities and across various state and local prisons that provide specialized prenatal care, mental health support, and reentry assistance. These programs are designed to address specific health disparities, particularly for racial and ethnic minority groups, by offering culturally competent care, nutrition counseling, and opportunities to maintain contact with newborn children. Additionally, the act requires an independent oversight organization to monitor program implementation and mandates a Government Accountability Office report to analyze maternal and infant health data within the correctional system.
The MOMMIES Act expands Medicaid and CHIP coverage for low-income pregnant and postpartum individuals by extending continuous benefits for one year after childbirth and mandating full coverage of oral health services. To support these changes, the bill includes maintenance of effort provisions that prevent states from restricting eligibility or reducing benefits for this population, alongside a temporary 100 percent federal funding match for states that increase spending on these services. Additionally, the legislation establishes a five-year demonstration project to fund maternity care home models that integrate medical and social support services, while also requiring studies and guidance on improving access to doula services and telehealth for maternity care.
The Anti-Fraud Fund Act of 2026 increases funding for the Health Care Fraud and Abuse Control Account by $7 billion annually from fiscal year 2027 through 2030. This additional money is intended to support the government's efforts in detecting and preventing fraud within the healthcare system. The bill modifies existing laws to ensure these funds are available for the specified period without altering other spending limits.
The SAFE Rural Act creates a new funding program to help rural communities, Tribal lands, and territories prepare for floods before disasters occur. It establishes a dedicated fund that receives 2% of annual disaster relief money to provide formula-based grants to States and Tribal governments for projects like restoring wetlands, upgrading drainage, and building resilient infrastructure. To ensure these funds reach smaller towns, the bill requires States to pass the money down as subgrants to local governments with populations of 50,000 or fewer, while also offering a simplified application process for small projects under $500,000. The legislation further mandates that recipients submit streamlined plans for maintaining their projects long-term and sets aside specific grants to build local capacity for managing hazard mitigation programs.
The Online Sellers' Bill of Rights Act of 2026 aims to protect third-party businesses using major online marketplaces by requiring these platforms to provide greater transparency and due process. Under the bill, the Federal Trade Commission must create rules that limit how long platforms can hold inventory or freeze funds, mandate written notice within 72 hours for any restrictions, and ensure sellers receive at least 30 days' warning before significant policy changes. The law also establishes a presumption of innocence, placing the burden of proof on the platform to demonstrate a violation rather than on the seller, and allows for specific appeals processes. Enforcement is handled through the FTC, which can pursue violations as unfair competition, while state attorneys general and individual sellers retain the right to file civil lawsuits for damages.
The SCALE Biology Act directs the National Institute of Standards and Technology to create a new biometrology laboratory program focused on engineering biology and biomanufacturing. This initiative aims to improve the accuracy and reliability of biological data while developing technical standards, safety guidelines, and measurement tools to support industry innovation and national security. The bill authorizes funding over several years to establish research facilities, train experts, and collaborate with universities and private companies to advance the field. Additionally, the legislation updates existing definitions related to biotechnology and biosafety to ensure clarity across federal programs.
The Next-Generation Geothermal Research and Development Act expands federal geothermal research to include advanced technologies like closed-loop and supercritical systems. It directs the Department of Energy to create a new research program, establish a center of excellence, and award grants for developing drilling equipment and materials needed for these systems. The bill also requires the creation of a public database for geothermal data and mandates periodic reports on water usage and the commercial potential of next-generation geothermal energy.
This bill, known as the STOP Nitazenes Act, directs the federal government to permanently classify nitazenes and related synthetic opioids as Schedule I controlled substances, placing them in the same legal category as heroin and fentanyl. The legislation specifically targets a broad range of chemical compounds, including etonitazene and other variants, by defining them as 2-benzylbenzimidazole opioids and requiring the Attorney General to publish a list of qualifying substances. Under the bill, any nitazene substance temporarily scheduled under emergency provisions would be made permanently scheduled upon enactment, ensuring long-term federal control. The law also mandates that the Attorney General issue implementing rules within one year, allowing for immediate interim enforcement while providing opportunities for public comment before final regulations are established.
This bill reauthorizes and modifies the American Battlefield Protection Program through 2035, extending funding deadlines and increasing grant percentages for battlefield preservation. It raises the maximum federal share for battlefield acquisition, interpretation, and restoration grants from 50% to 75% and sets a $2 million annual appropriation for these programs. The bill also mandates new studies to identify, assess, and propose preservation options for sites tied to the French and Indian War (1754-1763) and Mexican-American War (1846-1848), requiring consultation with states, tribes, and preservation groups. The studies must be completed within two years and reported to Congress, focusing on site significance, threats, and potential preservation strategies.
The SAFE CATTLE Act requires the U.S. Departments of Agriculture and Interior to coordinate federal efforts to prevent, monitor, and eradicate New World screwworm - a pest that attacks livestock and wildlife - across federal lands managed by agencies like the National Park Service and Fish and Wildlife Service. It mandates joint surveillance protocols, outbreak response plans with state officials, and science-based strategies to protect livestock industries and food supply chains. The bill also requires annual reports to Congress detailing interagency progress, outbreak responses, and recommendations for improving pest control until screwworm is contained south of Panama. This legislation directly affects federal land managers, livestock producers, and the broader agricultural economy by establishing a formal federal framework for addressing this specific animal health threat.
